Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Kolberg

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|February 26, 2013
SNAP-tag technology: a general introductionKatharina Kolberg, Christiane Puettmann, Alessa Pardo, et al.
Immunology Letters|October 23, 2012
A monoclonal antibody for the detection of SNAP/CLIP-tagged proteinsChristiane Puettmann, Katharina Kolberg, Sven Hagen, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2017
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancerClaudia Kessler, Alessa Pardo, Mehmet K Tur, et al.
Oncotargets and Therapy|July 26, 2017
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cellsMira Woitok, Diana Klose, Stefano Di Fiore, et al.
Cancer Letters|August 10, 2016
The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin FMira Woitok, Diana Klose, Judith Niesen, et al.
Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.
International Journal of Cancer|April 3, 2016
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion proteinManal Amoury, Radoslav Mladenov, Thomas Nachreiner, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 9, 2017
Fine Tuning Antibody Conjugation Methods using SNAP-tag TechnologyKarinna Chouman, Mira Woitok, Radoslav Mladenov, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|February 26, 2013
SNAP-tag technology: a general introductionKatharina Kolberg, Christiane Puettmann, Alessa Pardo, et al.
Immunology Letters|October 23, 2012
A monoclonal antibody for the detection of SNAP/CLIP-tagged proteinsChristiane Puettmann, Katharina Kolberg, Sven Hagen, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2017
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancerClaudia Kessler, Alessa Pardo, Mehmet K Tur, et al.
Oncotargets and Therapy|July 26, 2017
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cellsMira Woitok, Diana Klose, Stefano Di Fiore, et al.
Cancer Letters|August 10, 2016
The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin FMira Woitok, Diana Klose, Judith Niesen, et al.
Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.
International Journal of Cancer|April 3, 2016
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion proteinManal Amoury, Radoslav Mladenov, Thomas Nachreiner, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 9, 2017
Fine Tuning Antibody Conjugation Methods using SNAP-tag TechnologyKarinna Chouman, Mira Woitok, Radoslav Mladenov, et al.
Pageof 1